| 摘要 |
The present invention relates to at least one improved human GLP-1 mimeti body or specified portion or variant, including isolated nucleic acids that encode at least one GLP-1 mimetibody or specified portion or variant, GLP-1 mimetibody or specified portion or variants, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including thera peutic compositions, methods and devices. |
